2‐Butyl‐4‐oxo‐3‐{[2′‐(1H‐tetra­zol‐5‐yl)biphenyl‐4‐yl]meth­yl}‐3‐aza‐1‐azoniaspiro­[4.4]non‐1‐ene chloride 1.69‐hydrate (irbesartan hydrochloride 1.69‐hydrate)

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-5368|63|4|o1529-o1531

ISSN： 1600-5368

Source： Acta Crystallographica Section E, Vol.63, Iss.4, 2007-04, pp. : o1529-o1531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

2‐n‐Butyl‐3‐[2′‐(1H‐tetrazol‐5‐yl)biphenyl‐4‐ylmethyl]‐1‐azonia‐3‐azaspiro[4.4]non‐1‐en‐4‐one bromide sesquihydrate

By  

Acta Crystallographica Section E, Vol. 63, Iss. 12, 2007-12 ,pp. : o4933-o4933

John Wiley & Sons Inc

Access to resources Recommend Favorite

2,3‐Bis[(1‐phenyl‐1H‐tetra­zol‐5‐ylsulfan­yl)meth­yl]quinoxaline

By  

Acta Crystallographica Section E, Vol. 62, Iss. 7, 2006-07 ,pp. : o2817-o2818

John Wiley & Sons Inc

Access to resources Recommend Favorite

cyclo‐Tetra­kis[4‐(amino­meth­yl)‐5‐(hydroxy­meth­yl)‐2‐methyl­pyridin‐3‐olato‐κN1:κ2N4,O3]tetra­kis[chloro­palladium(II)] nona­hydrate

By  

Acta Crystallographica Section E, Vol. 62, Iss. 10, 2006-10 ,pp. : m2419-m2421

John Wiley & Sons Inc

Access to resources Recommend Favorite

O,O‐Diethyl [({1‐[(2‐chloro­thia­zol‐5‐yl)meth­yl]‐5‐methyl‐1H‐1,2,3‐triazol‐4‐yl}carbon­yloxy)phenyl­meth­yl]phospho­nate

By  

Acta Crystallographica Section E, Vol. 63, Iss. 1, 2007-01 ,pp. : o158-o160

John Wiley & Sons Inc

Access to resources Recommend Favorite

2‐(1H‐Tetra­zol‐1‐yl)ethanol

By  

Acta Crystallographica Section E, Vol. 63, Iss. 4, 2007-04 ,pp. : o1573-o1574

John Wiley & Sons Inc

Access to resources Recommend Favorite